Additive effects of obstructive sleep apnea syndrome and hypertension on inflammatory reaction

African Journal of Biotechnology

Volumn 10, Issue 55, 2011, Pages 11738-11744

  Liu, Zhi ^a   Xu, Yueqiao ^a   Hua, Qi ^a   Wang, Yanling ^a   Liu, Rongkun ^a   Yang, Zheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Arteriosclerosis; Hypertension; Inflammatory processes; Obstructive sleep apnea syndrome; Risk

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; APNEA HYPOPNEA INDEX; ARTERIOSCLEROSIS; ARTICLE; BLOOD GAS PARAMETERS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXYGEN DESATURATION; PATHOGENESIS; POLYSOMNOGRAPHY; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME;

EID: 80053057951     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Academy of Sleep Medicine (2007). The AASM manual for the scoring of Formatted: English (U.S.)sleep and associated events: rules, terminology and technical specifications. American Academy of Sleep Medicine.
2. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A, Kales A (2000). Association of hypertension and sleep-disordered breathing. Arch. Int. Med. 160(15): 2289-2295.
3. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA (1997). Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J. Clin. Invest. 99(1): 106-109.
4. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C (2004). Association between prehypertension status and inflammatory markers related to atherosclerotic desease: The ATTICA study. Am J. Hypertens, 17(7): 568-573.
5. Constantinidis J, Ereliadis S, Angouridakis N, Konstantinidis I Drager LZ, Bortolotto LA, Krieger EM, Lorenzi-Filho G (2009). Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension, 53(1): 64-69.
6. Dyugovskaya L, Lavie P, Lavie L (2002).Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit Care Med., 165(7): 934-939.
7. Gami AS, Somers VK (2004). Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur. Heart J. 25(9): 709-711.
8. Golias C, Tsoutsi E, Matziridis A, Batistatou A, Charalabopoulos KL (2007). Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo, 21(5): 757-769
9. Grote L, Hedner J, Peter JH (2000). Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J. Hypertens, 18(6): 679-685
10. Iber C, Ancoli-Israel S, Chesson A, Quan SF, for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. American Academy of Sleep Medicine; 2007.
11. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J (2001). Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest, 119(4): 1085-1091.
12. Lavie L (2003). Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med. Rev. 7(1): 35-51.
13. Liu H, Liu J, Xiong S, Shen G, Zhang Z, Xu Y (2000).The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J. Tongji Med. Univ. 20(3): 200-202.
14. Marin JM, Carrizo SJ, Vicente E, Agusti AG(2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 365(9464): 1046-1053.
15. Mohsenin V, Yaqqi HK, Shah N, Dziura J (2009). The effect of gender on the prevalence of hypertension in obstructive sleep apnea, Sleep Medicine, 10(7): 759-762
16. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA (2004). Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J. Respir. Crit. Care Med. 169(3): 354-360.
17. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG (2000). Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA, 283(14): 1829-1836.
18. Peppard PE, Young T, Palta M, Skatrud J (2000). Prospective study of the association between sleep-disorder breathing and hypertension. N. Engl. J. Med. 342(19): 1378-1384
19. Peppard PE, Young T, Palta M, Skatrud J (2000). Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med. 342(19): 1378-1384.
20. Phillips CL, Cistulli PA (2006). Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects. Minerva Medica, 97(4): 299-312.
21. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto, O'Connor GT, Boland LL, Schwartz JE, Samet JM (2001). Sleep-disordered breathing and cardiovascular disease: crosssectional results of the Sleep Health Study. Am J. Respir. Crit. Care Med. 163(1): 19-25.
22. Suematsu M, Suzuki H, Delano FA, Schmid-Schönbein GW (2002). The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation, 9(4): 259-276.
23. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC (1976). Hemodynamic in sleep-induced apnea: studies during wake fullness and sleep. Ann. Int. Med. 85(6): 714-719.
24. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP (1997). Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab. 82(5): 1313-1316.
25. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999). Elevated C-reactive protein levels in overweight and obese adults. JAMA, 282(22): 2131-2135
26. Vital V, Angouridaki C (2008). Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Euro. Arch. Otorhinolaryngol. 265(10): 1275-1279.
27. von Känel R, Jain S, Mills PJ, Nelesen RA, Adler KA, Hong S, Perez CJ, Dimsdale JE (2004). Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J. Hypertens, 22(11): 2087-2093.
28. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005). Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 353(19): 2034-2041.
29. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993). The occurrence of sleep-disordered breathing among middle-aged adults. Engl. J. Med. 328(17): 1230-235.
30. Young T, Peppard P, Gottlieb D (2002). Epidemiology of obstructive sleep apnea: a population health perspective. Am J. Respir. Crit. Care Med. 165(9): 1217-1239
31. Yu YM, Shen GL, Zhao ZG (2006). Study on the correlation between sleep aspnea syndrome and hypertension. J. Med. Theory Practice, 19(12): 894-895